Compare
February 22, 2025 2025-02-22 23:41Compare
Meline Volume remove | Monalisa Ultra Lidocaine remove | Elravie Premier Light-L remove | Slim Point Body remove | Rejeunesse Deep remove | Regenovue Sub-Q Plus remove | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Meline Volume remove | Monalisa Ultra Lidocaine remove | Elravie Premier Light-L remove | Slim Point Body remove | Rejeunesse Deep remove | Regenovue Sub-Q Plus remove | ||||||||||||
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||||||
SKU | FM-02-15536 | FM-02-15540 | FM-02-15517 | FM-04-74562 | FM-02-49152 | FM-02-15543 | ||||||||||||
Rating | ||||||||||||||||||
Price | $34.00 | $34.00 | $43.00 | $74.00 | $35.00 | $42.00 | ||||||||||||
Stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 998 in stock | 1000 in stock | ||||||||||||
Availability | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 998 in stock | 1000 in stock | ||||||||||||
Add to cart | ||||||||||||||||||
Description | ||||||||||||||||||
Content | Scope of Meline Volume Lidocaine:
| Monalisa Ultra Lidocaine is used for correction:
| Scope of Elravie Premier Light-L:
| Scope of Slim Point Body:
Product composition: Bromelain, Lecithin, Cyanocobalamin (vitamin B12) Slim Point Body 3 ampoules ? 30 ml per pack Manufacturer: Maypharm Co., Ltd., South Korea | Scope of Rejeunesse Deep:
The duration of the effect of 12-18 months. Product composition: HA 24 mg/ml, Lidocaine 0.3% Rejeunesse Deep 1 syringe ? 1.1 ml per pack Needle: 27G Manufacturer: Newmedic Co., Ltd., South Korea | Scope of Regenovue Sub-Q Plus:
The product has contraindications. We are not responsible for any negative effects that you may encounter after administering products by yourself. Consulting a doctor or medical professional is recommended prior to any procedure. | ||||||||||||
Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
Additional information |
|
|
|
|
|
|